Report cover image

Global Flu Shots Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 107 Pages
SKU # APRC20548435

Description

Summary

According to APO Research, The global Flu Shots market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Flu Shots include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Flu Shots, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Shots.
The Flu Shots market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flu Shots market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Flu Shots Segment by Company

SANOFI
GSK
VAXTEC
TIANYUAN BIO-PHARMA
SIOBP
SINOVAC
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
HUALAN BIO
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
Flu Shots Segment by Type

Influenza Whole Virus Vaccines
Influenza Virus Subunit Vaccines
Influenza Virus Split Vaccines
Flu Shots Segment by Application

Avian Influenza Virus-A
Avian Influenza Virus-B
Flu Shots Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flu Shots manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Flu Shots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

107 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Flu Shots Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Flu Shots Sales Estimates and Forecasts (2020-2031)
1.3 Flu Shots Market by Type
1.3.1 Influenza Whole Virus Vaccines
1.3.2 Influenza Virus Subunit Vaccines
1.3.3 Influenza Virus Split Vaccines
1.4 Global Flu Shots Market Size by Type
1.4.1 Global Flu Shots Market Size Overview by Type (2020-2031)
1.4.2 Global Flu Shots Historic Market Size Review by Type (2020-2025)
1.4.3 Global Flu Shots Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Flu Shots Sales Breakdown by Type (2020-2025)
1.5.2 Europe Flu Shots Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Flu Shots Sales Breakdown by Type (2020-2025)
1.5.4 South America Flu Shots Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Flu Shots Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Flu Shots Industry Trends
2.2 Flu Shots Industry Drivers
2.3 Flu Shots Industry Opportunities and Challenges
2.4 Flu Shots Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Flu Shots Revenue (2020-2025)
3.2 Global Top Players by Flu Shots Sales (2020-2025)
3.3 Global Top Players by Flu Shots Price (2020-2025)
3.4 Global Flu Shots Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Flu Shots Major Company Production Sites & Headquarters
3.6 Global Flu Shots Company, Product Type & Application
3.7 Global Flu Shots Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Flu Shots Market CR5 and HHI
3.8.2 Global Top 5 and 10 Flu Shots Players Market Share by Revenue in 2024
3.8.3 2023 Flu Shots Tier 1, Tier 2, and Tier 3
4 Flu Shots Regional Status and Outlook
4.1 Global Flu Shots Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Flu Shots Historic Market Size by Region
4.2.1 Global Flu Shots Sales in Volume by Region (2020-2025)
4.2.2 Global Flu Shots Sales in Value by Region (2020-2025)
4.2.3 Global Flu Shots Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Flu Shots Forecasted Market Size by Region
4.3.1 Global Flu Shots Sales in Volume by Region (2026-2031)
4.3.2 Global Flu Shots Sales in Value by Region (2026-2031)
4.3.3 Global Flu Shots Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Flu Shots by Application
5.1 Flu Shots Market by Application
5.1.1 Avian Influenza Virus-A
5.1.2 Avian Influenza Virus-B
5.2 Global Flu Shots Market Size by Application
5.2.1 Global Flu Shots Market Size Overview by Application (2020-2031)
5.2.2 Global Flu Shots Historic Market Size Review by Application (2020-2025)
5.2.3 Global Flu Shots Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Flu Shots Sales Breakdown by Application (2020-2025)
5.3.2 Europe Flu Shots Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Flu Shots Sales Breakdown by Application (2020-2025)
5.3.4 South America Flu Shots Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Flu Shots Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 SANOFI
6.1.1 SANOFI Comapny Information
6.1.2 SANOFI Business Overview
6.1.3 SANOFI Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.1.4 SANOFI Flu Shots Product Portfolio
6.1.5 SANOFI Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Flu Shots Product Portfolio
6.2.5 GSK Recent Developments
6.3 VAXTEC
6.3.1 VAXTEC Comapny Information
6.3.2 VAXTEC Business Overview
6.3.3 VAXTEC Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.3.4 VAXTEC Flu Shots Product Portfolio
6.3.5 VAXTEC Recent Developments
6.4 TIANYUAN BIO-PHARMA
6.4.1 TIANYUAN BIO-PHARMA Comapny Information
6.4.2 TIANYUAN BIO-PHARMA Business Overview
6.4.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.4.4 TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
6.4.5 TIANYUAN BIO-PHARMA Recent Developments
6.5 SIOBP
6.5.1 SIOBP Comapny Information
6.5.2 SIOBP Business Overview
6.5.3 SIOBP Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.5.4 SIOBP Flu Shots Product Portfolio
6.5.5 SIOBP Recent Developments
6.6 SINOVAC
6.6.1 SINOVAC Comapny Information
6.6.2 SINOVAC Business Overview
6.6.3 SINOVAC Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SINOVAC Flu Shots Product Portfolio
6.6.5 SINOVAC Recent Developments
6.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
6.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Comapny Information
6.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
6.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
6.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
6.8 HUALAN BIO
6.8.1 HUALAN BIO Comapny Information
6.8.2 HUALAN BIO Business Overview
6.8.3 HUALAN BIO Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.8.4 HUALAN BIO Flu Shots Product Portfolio
6.8.5 HUALAN BIO Recent Developments
6.9 CHANGSHENG
6.9.1 CHANGSHENG Comapny Information
6.9.2 CHANGSHENG Business Overview
6.9.3 CHANGSHENG Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CHANGSHENG Flu Shots Product Portfolio
6.9.5 CHANGSHENG Recent Developments
6.10 CCBIO
6.10.1 CCBIO Comapny Information
6.10.2 CCBIO Business Overview
6.10.3 CCBIO Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CCBIO Flu Shots Product Portfolio
6.10.5 CCBIO Recent Developments
6.11 ALEPH BIOMEDICAL
6.11.1 ALEPH BIOMEDICAL Comapny Information
6.11.2 ALEPH BIOMEDICAL Business Overview
6.11.3 ALEPH BIOMEDICAL Flu Shots Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ALEPH BIOMEDICAL Flu Shots Product Portfolio
6.11.5 ALEPH BIOMEDICAL Recent Developments
7 North America by Country
7.1 North America Flu Shots Sales by Country
7.1.1 North America Flu Shots Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Flu Shots Sales by Country (2020-2025)
7.1.3 North America Flu Shots Sales Forecast by Country (2026-2031)
7.2 North America Flu Shots Market Size by Country
7.2.1 North America Flu Shots Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Flu Shots Market Size by Country (2020-2025)
7.2.3 North America Flu Shots Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Flu Shots Sales by Country
8.1.1 Europe Flu Shots Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Flu Shots Sales by Country (2020-2025)
8.1.3 Europe Flu Shots Sales Forecast by Country (2026-2031)
8.2 Europe Flu Shots Market Size by Country
8.2.1 Europe Flu Shots Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Flu Shots Market Size by Country (2020-2025)
8.2.3 Europe Flu Shots Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Flu Shots Sales by Country
9.1.1 Asia-Pacific Flu Shots Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Flu Shots Sales by Country (2020-2025)
9.1.3 Asia-Pacific Flu Shots Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Flu Shots Market Size by Country
9.2.1 Asia-Pacific Flu Shots Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Flu Shots Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Flu Shots Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Flu Shots Sales by Country
10.1.1 South America Flu Shots Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Flu Shots Sales by Country (2020-2025)
10.1.3 South America Flu Shots Sales Forecast by Country (2026-2031)
10.2 South America Flu Shots Market Size by Country
10.2.1 South America Flu Shots Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Flu Shots Market Size by Country (2020-2025)
10.2.3 South America Flu Shots Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Flu Shots Sales by Country
11.1.1 Middle East and Africa Flu Shots Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Flu Shots Sales by Country (2020-2025)
11.1.3 Middle East and Africa Flu Shots Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Flu Shots Market Size by Country
11.2.1 Middle East and Africa Flu Shots Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Flu Shots Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Flu Shots Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Flu Shots Value Chain Analysis
12.1.1 Flu Shots Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Flu Shots Production Mode & Process
12.2 Flu Shots Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Flu Shots Distributors
12.2.3 Flu Shots Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.